Loading...
Every company here put through the same five checks on growth and cash generation. It describes the industry as it reports today — not which of these to buy.
| DDS | DILLARD’S, INC. | D+ | $9.7B | $621.00 | 14.23 | $6.6B | 10.3% |
| M | Macy's, Inc. | B | $6.5B | $24.83 | 9.10 | $22.8B | 3.3% |
| KSS | KOHL’S CORP | D | $2.8B | $24.67 | 10.73 | $15.4B | 1.7% |
| PLBL | Polibeli Group Ltd | F- | $2.1B | $5.67 | — | $20.7M | -9.4% |
Fundamentals from SEC filings, prices from the last market-data pass. Sort by any column; companies with no figure sort last either way.
Sorted by market cap, largest first; click any column to re-sort. Companies with no figure sort last either way, because a missing P/E means unprofitable rather than cheap. Nothing here is a recommendation.